Back to News
Market Impact: 0.45

Amex (AXP) Q3 2026 Earnings Call Transcript

Source: The Motley Fool

+3
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsConsumer Demand & RetailCredit & Bond MarketsCapital Returns (Dividends / Buybacks)Artificial IntelligenceRegulation & Legislation

American Express reported Q3 revenue of $20.1 billion, up 9% year over year, and adjusted EPS of $4.68, up 13% after excluding the Global Business Travel gain and restructuring charge. The company raised its 2026 reported EPS guidance to $18.30–$18.60, while reaffirming 10% revenue growth guidance; card spending rose 8% and net card fees increased 17% on an FX-adjusted basis. Results also included a $336 million restructuring charge tied to planned elimination of approximately 5% of global positions, alongside legal reserves related in part to an OCC civil money penalty. Amex returned $2.2 billion to shareholders and cited AI, including agentic commerce initiatives, as a strategic investment area.

Analysis

The earnings quality is better than reported EPS suggests, but not as clean as adjusted EPS implies: the quarter’s reserve-model release and other discrete items flatter the underlying run rate, while the divestiture gain should not be capitalized. The more durable signal is fee-led growth paired with premium customer acquisition; the key near-term test is whether spend and fee momentum hold as the Platinum refresh laps and VCE growth normalizes. If they do, lower incremental benefit-cost growth could support operating leverage without requiring faster revolving balances.

The market may underweight two offsets. First, rewards optimization via AI is not purely a cost threat: Amex can use its closed-loop data and product controls to steer engagement, but customer benefit usage could still pressure VCE before monetization catches up. Second, international acceptance and the Airbnb channel are strategic distribution assets, not yet evidence of material incremental earnings. For Airbnb, the partnership may add qualified travel discovery, but bookings, conversion, and economics remain unverified.

Credit remains a watch item rather than a clean all-clear: stable reported delinquencies coexist with a model-driven reserve release, so a macro shock could expose less cushion than headline provision suggests. The regulatory remediation is also an execution risk; no asset cap is stated, but delayed control fixes could bring additional cost or restrictions. Over 6–18 months, Amex’s middle-market commercial gap versus Ramp and Brex is a meaningful growth constraint until the Center capabilities demonstrate adoption. The call supports a moderately constructive AXP view, not an unconditional rerating.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.45

Ticker Sentiment

ABNB0.35
AXP0.65
BFH0.25
COF-0.10
MA-0.10
SYF0.20
V-0.10

Key Decisions for Investors

  • AXP: Consider a staged long on post-earnings weakness rather than chasing the print; the thesis is fee-led growth plus easing VCE growth, with Q4 the first read-through. Reassess if net card-fee growth decelerates materially, VCE as a share of revenue rises, or guidance is cut.
  • Do not treat the reserve release as recurring earnings or extrapolate the credit trend without checking subsequent delinquency, write-off, and allowance data. A meaningful deterioration in those measures would invalidate the benign-credit premise and weaken the long thesis.
  • Keep the OCC remediation on the event calendar for the next 1–3 months: monitor disclosed remediation milestones, legal reserves, and any regulatory action. Further penalties, operating restrictions, or unexpected control costs warrant reducing AXP exposure.
  • ABNB: Watch, rather than trade, the Amex channel announcement until the companies disclose evidence of booking conversion or incremental economics. Listing availability alone does not establish revenue impact.

More News

From AllMind Research

Browse all research